The Clinical Genome Resource Consortium team at UNC-Chapel Hill, led by Jonathan Berg, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, was awarded a $24-million, five-year grant to scale biocuration and expert evaluation of genes and variants.
Read More
Xilis, a startup founded by two professors at Duke University focusing on technology to boost precision health and oncology, has landed $70 million in new funding with Google Ventures among the backers.
Read More
Metabolon, a precision medicine company based in RTP, has raised roughly $21.8 million in equity. But it wants a lot more. Heres whats happening.
Read More
That brings the total raised to roughly $4.85 since December 2019. Eight investors contributed to the round.
Read More
RESEARCH TRIANGLE PARK – From “find it and fix it” to “anticipate and mitigate.” That’s how Ralph Snyderman, M.D. — chancellor emeritus at Duke University — explains the journey from traditional medicine to personalized healthcare, which is playing an increasingly important role at clinics and hospitals across the country....
Read More
Analysis of genetic information – the blueprint of life within our cells that we inherit from our parents – is transforming biotechnology and healthcare.
Read More
Recent advances in genomics, coupled with lower costs, have kicked population screening into a higher gear. And that has opened the door to tremendous opportunity.
Read More
LabCorp is offering a new assay to help doctors monitor drug responses in patients taking Certolizumab, a biologic therapy for certain inflammatory diseases such as rheumatoid arthritis and Crohn’s disease.
Read More
The promise of precision medicine, first realized with the mapping of the human genome more than two decades ago, is fast becoming a reality. And it is transforming healthcare as we know it. A recent conference at Duke University featured updates on promising programs.
Read More
